ADA Scientific Sessions 2025 Abstract·13 JunPost Hoc Analysis of Efsubaglutide Alfa Monotherapy and Combined Therapy with Metformin in T2D Patients by Baseline CharacteristicsTrial in peopleInterventionsPaper